Suto K, Takei N, Yokoyama K, Chiba M, et al. Genome-wide CRISPR screen identifies MAD2L1BP and ANAPC15 as targets for brentuximab vedotin sensitivity in CD30+ peripheral T-cell lymphoma. Leukemia 2024 Oct 21. doi: 10.1038/s41375-024-02441.
PMID: 39433928